Motoyoshi Yano Selected Research

Iron Overload

4/2024	A Revised Classification of Primary Iron Overload Syndromes.
10/2018	A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign.
9/2013	Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis.
6/2009	Special stain and X-ray probe microanalysis of livers with Wilson disease.
9/2006	Compound overload of copper and iron in patients with Wilson's disease.
9/2005	A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
9/2004	Improvement of serum bilirubin levels after venesection in a patient with Dubin-Johnson syndrome and HCV-positive chronic liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motoyoshi Yano Research Topics

Disease

9	Hepatolenticular Degeneration (Wilson's Disease) 03/2017 - 10/2005
7	Iron Overload 04/2024 - 09/2004
7	Chronic Hepatitis C 05/2011 - 01/2002
6	Hemochromatosis (Bronze Diabetes) 04/2024 - 03/2005
4	Hepatitis 04/2010 - 08/2006
4	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 10/2007 - 01/2003
3	Liver Diseases (Liver Disease) 01/2010 - 09/2004
2	Anemia 04/2024 - 02/2014
2	Hyperferritinemia 10/2018 - 09/2005
2	Liver Failure 09/2011 - 01/2010
2	Hepatitis B 04/2010 - 04/2007
2	Chronic Hepatitis (Chronic Active Hepatitis) 03/2009 - 04/2007
2	Hyperbilirubinemia 09/2004 - 01/2003
1	Hemorrhage 12/2023
1	Atrophy 10/2018
1	Fibrosis (Cirrhosis) 09/2011
1	Brain Diseases (Brain Disorder) 01/2010
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2010
1	Fatty Liver 06/2009
1	Chronic Hepatitis B 04/2007
1	Massive Hepatic Necrosis 08/2006
1	Hemophilia A (Haemophilia) 03/2005
1	Diabetes Mellitus 03/2005
1	Jaundice (Icterus) 09/2004
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2002
1	Inflammation (Inflammations) 01/2002

Drug/Important Bio-Agent (IBA)

13	IronIBA 04/2024 - 01/2002
8	CopperIBA 03/2017 - 08/2006
4	Familial apoceruloplasmin deficiencyIBA 04/2024 - 09/2006
3	metal transporting protein 1 (ferroportin)IBA 04/2024 - 09/2005
3	ATP-Binding Cassette Sub-Family B Member 4IBA 04/2005 - 01/2003
2	Transferrin (beta 2 Transferrin)IBA 04/2024 - 09/2005
2	EnzymesIBA 02/2014 - 01/2010
2	Idiopathic Copper ToxicosisIBA 09/2013 - 09/2011
2	Lamivudine (Epivir)FDA Link 04/2010 - 04/2007
2	Transaminases (Aminotransferases)IBA 01/2010 - 01/2002
2	Alanine Transaminase (SGPT)IBA 09/2004 - 06/2004
1	MetalsIBA 04/2024
1	HepcidinsIBA 01/2010
1	Ferritins (Ferritin)IBA 01/2010
1	Fixatives (Pickling Agents)IBA 06/2009
1	Coloring Agents (Dyes)IBA 06/2009
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 03/2009
1	Heme (Haem)IBA 08/2006
1	Malondialdehyde (Propanedial)IBA 08/2006
1	Trientine (Trien)FDA Link 10/2005
1	Blood Coagulation Factors (Coagulation Factor)IBA 03/2005
1	Ribavirin (Virazole)FDA LinkGeneric 03/2005
1	Transferrin Receptors (Transferrin Receptor)IBA 03/2005
1	Glucose (Dextrose)FDA LinkGeneric 03/2005
1	BilirubinIBA 09/2004
1	InterferonsIBA 09/2004

Therapy/Procedure

7	Therapeutics 05/2011 - 06/2004
1	Endoscopic Sphincterotomy 12/2023
1	Electrodes (Electrode) 12/2023
1	Drug Therapy (Chemotherapy) 01/2010
1	Aftercare (After-Treatment) 09/2006